GALL BLADDER CANCER
Clinical trials for GALL BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new GALL BLADDER CANCER trials appear
Sign up with your email to follow new studies for GALL BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to heat up 'Cold' tumors
Disease control Recruiting nowThis study tests whether combining two drugs—atezolizumab (an immunotherapy) and tivozanib (a targeted therapy)—can shrink tumors in cancers that usually don't respond to immunotherapy alone. About 29 adults with advanced bile duct, gallbladder, breast, neuroendocrine, ovarian, p…
Matched conditions: GALL BLADDER CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 16, 2026 12:55 UTC
-
Robot surgeons take on gallbladder cancer in global recovery showdown
Disease control Recruiting nowThis study compares robotic-assisted surgery to traditional open surgery for people with gallbladder cancer who need a radical cholecystectomy. About 94 participants from multiple countries will be randomly assigned to one of the two procedures. The main goal is to see which appr…
Matched conditions: GALL BLADDER CANCER
Phase: NA • Sponsor: Karolinska University Hospital • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New hope for hard-to-treat cancers: drug shows promise in real-world study
Disease control Recruiting nowThis study looks at how well the drug T-DXd works for adults with advanced HER2-positive solid tumors who have already tried other treatments and have no good alternatives. About 100 people will take T-DXd as part of their regular care, and researchers will track tumor shrinkage …
Matched conditions: GALL BLADDER CANCER
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 08, 2026 13:05 UTC
-
New drug targets rare cancer mutation in 300-patient trial
Disease control Recruiting nowThis study tests a new drug called PC14586 (rezatapopt) in people with advanced solid tumors that have a specific change in the TP53 gene (Y220C mutation). The goal is to see if the drug is safe and shrinks tumors. About 300 adults whose cancer has worsened after prior treatment …
Matched conditions: GALL BLADDER CANCER
Phase: PHASE1, PHASE2 • Sponsor: PMV Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 03, 2026 12:06 UTC
-
Simple blood test could catch deadly bile duct cancers early
Diagnosis Recruiting nowThis study is testing a new blood test that looks for DNA changes from cancer cells to detect biliary tract cancers earlier and more accurately. The test aims to help doctors diagnose these aggressive cancers sooner and monitor how well treatment is working. Researchers will enro…
Matched conditions: GALL BLADDER CANCER
Sponsor: Yingbin Liu, MD, PhD, FACS • Aim: Diagnosis
Last updated Jun 15, 2026 19:05 UTC
-
New scan could spot bile duct cancers more accurately
Diagnosis Recruiting nowThis study looks at whether a new type of PET scan (FAPI PET/CT) can find and stage gallbladder and bile duct cancers better than the standard scan. About 60 adults with suspected or confirmed cancer will get both scans to compare accuracy. The goal is to improve detection of can…
Matched conditions: GALL BLADDER CANCER
Sponsor: Tata Memorial Centre • Aim: Diagnosis
Last updated Jun 08, 2026 13:09 UTC